Look For Capital In Biotech Sector: RCUS, MRK, XNCR, LPTX, ARGX, BPMC

<p>The biotech sector is down about 25% year-to-date. The SPDR S&amp;P Biotech ETF (XBI) has been bouncing back and forth. "I like Arcus Biosciences (RCUS) as they have a partnership with Gilead Sciences (GILD). The company has capital to keep it going. Other stock picks include Xencor (XNCR), Merck &amp; Co. (MRK), and Leap Therapeutics (LPTX)," says Mara Goldstein. Next, David Nierengarten weighs in on argenx SE (ARGX) and Blueprint Medicines (BPMC) stocks. </p><p><br></p>